X-Square Capital’s Pfizer PFE Stock Holding History

X-Square Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,778	Closed	-$359K	–	163
2023 Q3	$359K	Hold	9,778	–	–	0.24%	103
2023 Q2	$359K	Buy	9,778 +24	+0.2%	+$934	0.24%	103
2023 Q1	$398K	Buy	9,754 +3	+0%	+$130	0.23%	110
2022 Q4	$500K	Sell	9,751 -201	-2%	-$9.64K	0.28%	104
2022 Q3	$435K	Buy	9,952 +3	+0%	+$146	0.28%	98
2022 Q2	$522K	Buy	9,949 +3	+0%	+$153	0.31%	90
2022 Q1	$515K	Sell	9,946 -204	-2%	-$10.6K	0.27%	96
2021 Q4	$599K	Sell	10,150 -134	-1%	-$6.64K	0.3%	90
2021 Q3	$442K	Buy	10,284 +32	+0.3%	+$1.42K	0.23%	100
2021 Q2	$401K	Buy	10,252 +351	+4%	+$13.7K	0.19%	102
2021 Q1	$359K	Buy	9,901 +635	+7%	+$22.5K	0.17%	95
2020 Q4	$341K	Sell	9,266 -201	-2%	-$7.37K	0.18%	90
2020 Q3	$330K	Sell	9,467 -4,738	-33%	-$166K	0.24%	74
2020 Q2	$441K	Buy	14,205 +672	+5%	+$22.8K	0.31%	60
2020 Q1	$419K	Buy	13,533 +2,761	+26%	+$94.1K	0.42%	51
2019 Q4	$400K	Buy	10,772 +425	+4%	+$15.1K	0.24%	57
2019 Q3	$353K	Buy	10,347 +3,047	+42%	+$111K	0.22%	50
2019 Q2	$300K	Buy	+7,300	New	+$290K	0.19%	54

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

X-Square Capital's PFE Position: Q4 2023 in Review

X-Square Capital sold out of Pfizer (PFE) in Q4 2023, closing a stake of 9,778 shares — an estimated $359K sold.

X-Square Capital first reported a position in PFE in Q2 2019 and held it in 18 quarters. The position peaked at $599K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

X-Square Capital reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
X-Square Capital sold 9,778 Pfizer shares in Q4 2023, an estimated $359K.
X-Square Capital first reported a position in Pfizer in Q2 2019 and held it in 18 quarters.
X-Square Capital's Pfizer position peaked at $599K in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on X-Square Capital's 13F filing for Q4 2023, filed 9 Feb 2024.